Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells

Leukemia and Lymphoma

Volumn 41, Issue 3-4, 2001, Pages 397-409

  Otsuki, T ^a   Yamada, O ^a   Kurebayashi, J ^a   Sakaguchi, H ^a   Yata, K ^a   Uno, M ^a   Oka, T ^a   Yawata, Y ^a   Ueki, A ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Myeloma; PMA; PTH PTHrP receptor; PTHrP; TGF

Indexed keywords

HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE LESION; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HYPERCALCEMIA; IN VITRO STUDY; MALE; MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0034980787     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057995     Document Type: Article

References (42)

1. Multiple myeloma: Prognosis and standard treatment
2. Advances in the treatment of multiple myeloma
3. Myeloma bone disease
4. Mechanisms of bone lesions in multiple myeloma and lymphoma
5. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors
6. Bone marrow microenvironment and the progression of multiple myeloma
7. Hypercalcemia of malignancy
8. Parathyroid hormone-related peptide and hypercalcemia of malignancy
9. Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: A case report
10. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma
11. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma
12. Ultrastructure of myeloma cells producing parathyroid hormone-related peptide
13. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy
14. Parathyroid-hormone-related peptide in hematologic malignancies
15. Evidence for parathyroid hormone-related peptide as a cause of hypercalcemia in myeloma
16. Production of parathyroid hormone-related protein by cultured human myeloma cells
17. A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and interleukin-6 from a myeloma patient presenting with hypercalcaemia
18. Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro
19. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein
20. A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia
21. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma
22. Transforming growth factor-beta1 regulates steady-state PTH/PTHrP receptor mRNA levels and PTHrP binding in ROS 17/2.8 osteosarcoma cells
23. Effects of transforming growth factor-beta on the production of parathyroid hormone-related peptide in a human ovarian Cancer cell line in vitro
24. Effects of secretory products of breast cancer cells on osteoblast-like cells
25. Evidence for the synthesis of parathyroid hormone-related protein (PTHrP) by non-transformed clonal rat osteoblastic cells in vitro
26. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro
27. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide
28. Parathyroid hormone-related protein increases DNA synthesis in proximal tubule cells by cyclic AMP- and protein kinase C-dependent pathways
29. Malignant hematopoietic cell lines. In vitro models for the study of multiple myeloma and plasma cell leukemia
30. Myeloma and plasma cell leukemia cell lines
31. Establishment and characterization of a human myeloma cell line (KMM-1)
32. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)
33. Establishment of five human myeloma cell lines
34. Down regulation of protein kinase C during growth enhancement induced by interleukin-6 on a human myeloma cell line, KMS-11
35. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;132.3) derived from a case phenotypically transformed from Ig A-1 to BJP-1, and associated with hyperamonemia
36. A new human breast Cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice
37. Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells
38. Isolation and characterisation of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
39. A new human breast Cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice
40. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection
41. Calcium-dependent homotypic adhesion through leukocyte function-associated antigen-1/intracellular adhesion molecule-1 induces interleukin-1 and parathyroid hormone-related protein production on adult T-cell leukemia cells in vitro
42. Parathyroid hormone-related protein-induced hypercalcemia in SCID mice engrafted with adult T-cell leukemia cells